Ignite Creation Date:
2025-12-24 @ 12:54 PM
Ignite Modification Date:
2026-01-08 @ 7:12 PM
Study NCT ID:
NCT04115761
Status:
RECRUITING
Last Update Posted:
2024-09-19
First Post:
2019-10-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate the Efficacy and Safety of ADCV01 As an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients
Sponsor:
Ever Supreme Bio Technology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-06-06
Start Date Type:
ACTUAL
Primary Completion Date:
2026-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-10-02
First Submit QC Date:
None
Study First Post Date:
2019-10-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-10
Last Update Post Date:
2024-09-19
Last Update Post Date Type:
ACTUAL